PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

NCT01700920 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Red de Terapia Celular

Collaborators